TNF Pharmaceuticals, Inc. Quarterly Common Stock, Shares, Issued from Q4 2012 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
TNF Pharmaceuticals, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2012 to Q3 2024.
  • TNF Pharmaceuticals, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 2.47M shares, a 94.7% decline year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 2.47M -44.5M -94.7% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 2.37M -39.7M -94.4% Jun 30, 2024 10-Q 2024-08-19
Q1 2024 2.16M -37.3M -94.5% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 2.02M +703K +53.4% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 47M +7.53M +19.1% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 42M +3.97M +10.4% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 39.5M +1.41M +3.71% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 1.32M -36.4M -96.5% Dec 31, 2022 10-K 2024-04-01
Q3 2022 39.5M Sep 30, 2022 10-Q 2022-11-10
Q2 2022 38.1M +38.1M Jun 30, 2022 10-Q 2022-08-15
Q1 2022 38.1M +29.7M +357% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 37.7M +9.12M +31.9% Dec 31, 2021 10-K 2023-03-31
Q2 2021 0 -6.13M -100% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 8.33M +5.41M +186% Mar 31, 2021 10-Q 2021-05-18
Q4 2020 28.6M +26.8M +1542% Dec 31, 2020 10-Q 2021-08-16
Q3 2020 8.86M -3.66M -29.2% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 6.13M -6.38M -51% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 2.92M -9.58M -76.7% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 1.74M +1.2M +222% Dec 31, 2019 10-K 2021-03-01
Q3 2019 12.5M +737K +6.26% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 12.5M -81.6M -86.7% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 12.5M -73.9M -85.5% Mar 31, 2019 10-Q 2019-05-20
Q4 2018 541K -4.99M -90.2% Dec 31, 2018 10-K 2020-03-25
Q3 2018 11.8M +2.88M +32.3% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 94.1M +85.2M +957% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 86.4M +77.6M +876% Mar 31, 2018 10-Q 2018-07-13
Q4 2017 5.53M +82.1K +1.51% Dec 31, 2017 10-K 2019-04-01
Q3 2017 8.9M +3.45M +63.2% Sep 30, 2017 10-Q/A 2018-07-13
Q2 2017 8.9M +3.45M +63.2% Jun 30, 2017 10-Q/A 2018-07-13
Q1 2017 8.85M +3.43M +63.2% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 5.45M +27.5K +0.51% Dec 31, 2016 10-K/A 2018-07-13
Q3 2016 5.45M +308K +5.98% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 5.45M +308K +5.98% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 5.43M +280K +5.45% Mar 31, 2016 10-Q 2016-05-12
Q4 2015 5.43M +470K +9.49% Dec 31, 2015 10-K 2017-04-11
Q3 2015 5.14M +190K +3.84% Sep 30, 2015 10-Q 2015-11-13
Q2 2015 5.14M +250K +5.11% Jun 30, 2015 10-Q 2015-08-18
Q1 2015 5.14M +250K +5.11% Mar 31, 2015 10-Q 2015-05-14
Q4 2014 4.95M +2.79M +129% Dec 31, 2014 10-K 2017-04-11
Q3 2014 4.95M Sep 30, 2014 10-Q 2014-11-13
Q2 2014 4.89M +4.38M +854% Jun 30, 2014 10-Q 2014-08-12
Q1 2014 4.89M Mar 31, 2014 10-Q 2014-05-14
Q4 2013 2.17M +889K +69.5% Dec 31, 2013 10-K 2016-03-30
Q2 2013 513K Jun 12, 2013 10-K 2015-03-23
Q4 2012 1.28M Dec 31, 2012 10-K 2015-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.